FDA reports new deaths in U.S. with diabetes drug Byetta

WASHINGTON - U.S. federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. as deaths continue to be reported despite earlier government warnings....More